Nano-X Imaging Expands FDA Clearance for Nanox.ARC

Nano-X Imaging (NNOX) has released an update.

Nano-X Imaging’s Nanox.ARC system has received FDA clearance for broader use, including pulmonary and intra-abdominal imaging, enhancing its capabilities beyond musculoskeletal applications. This innovative digital X-ray technology, now deployed across seven U.S. states, aims to offer cost-effective and advanced diagnostic imaging, potentially transforming patient care and reducing wait times. With its unique design, the Nanox.ARC promises to integrate seamlessly into healthcare facilities, providing a compact and efficient imaging solution.

For further insights into NNOX stock, check out TipRanks’ Stock Analysis page.